docetaxel,darolutamide
bayer,novo nordisk
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'docetaxel', 'arasens', 'darolutamide', 'novo ']
updated #arasens results show os benefit w/ triplet therapy (adt + docetaxel x6c + darolutamide) regardless of volume/risk stratification. *large % are de novo #gu23 
PGY-5 Heme/Onc Fellow @UKMarkey